AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
less 20 24 20 24 O
than 25 29 25 29 O
or 30 32 30 32 O
equal 33 38 33 38 O
to 39 41 39 41 O
3 42 43 42 43 B-upper_bound
X 44 45 44 45 I-upper_bound
institutional 46 59 46 59 I-upper_bound
upper 60 65 60 65 I-upper_bound
limit 66 71 66 71 I-upper_bound
of 72 74 72 74 I-upper_bound
normal 75 81 75 81 I-upper_bound
; 81 82 81 82 O
5.0 83 86 83 86 O
x 87 88 87 88 O
ULN 89 92 89 92 O
in 93 95 93 95 O
cases 96 101 96 101 O
of 102 104 102 104 O
liver 105 110 105 110 B-cancer
metastases 111 121 111 121 I-cancer

Ability 0 7 122 129 O
to 8 10 130 132 O
understand 11 21 133 143 O
and 22 25 144 147 O
the 26 29 148 151 O
willingness 30 41 152 163 O
to 42 44 164 166 O
sign 45 49 167 171 O
a 50 51 172 173 O
written 52 59 174 181 O
informed 60 68 182 190 O
consent 69 76 191 198 O
document 77 85 199 207 O
and 86 89 208 211 O
to 90 92 212 214 O
undergo 93 100 215 222 O
tumor 101 106 223 228 B-cancer
biopsies 107 115 229 237 B-treatment
in 116 118 238 240 O
the 119 122 241 244 O
expansion 123 132 245 254 O
phase 133 138 255 260 O

Absolute 0 8 261 269 B-clinical_variable
neutrophil 9 19 270 280 I-clinical_variable
count 20 25 281 286 I-clinical_variable
greater 26 33 287 294 O
than 34 38 295 299 O
1,500 39 44 300 305 B-lower_bound
/ 44 45 305 306 I-lower_bound
mcL 45 48 306 309 I-lower_bound

Adequately 0 10 310 320 O
managed 11 18 321 328 O
stage 19 24 329 334 B-lower_bound
0 25 26 335 336 I-lower_bound
( 27 28 337 338 O
carcinoma 28 37 338 347 B-cancer
in 38 40 348 350 I-cancer
situ 41 45 351 355 I-cancer
) 45 46 355 356 O
, 46 47 356 357 O
I 48 49 358 359 O
, 49 50 359 360 O
or 51 53 361 363 O
II 54 56 364 366 B-upper_bound
basal 57 62 367 372 B-cancer
cell 63 67 373 377 I-cancer
or 68 70 378 380 O
squamous 71 79 381 389 B-cancer
cell 80 84 390 394 I-cancer
carcinoma 85 94 395 404 I-cancer
from 95 99 405 409 O
which 100 105 410 415 O
the 106 109 416 419 O
patient 110 117 420 427 O
is 118 120 428 430 O
currently 121 130 431 440 O
in 131 133 441 443 O
complete 134 142 444 452 O
remission 143 152 453 462 O

Adequately 0 10 463 473 O
managed 11 18 474 481 O
stage 19 24 482 487 B-lower_bound
I 25 26 488 489 I-lower_bound
or 27 29 490 492 O
II 30 32 493 495 B-upper_bound
well 33 37 496 500 O
differentiated 38 52 501 515 O
thyroid 53 60 516 523 B-cancer
or 61 63 524 526 O
prostate 64 72 527 535 B-cancer
cancer 73 79 536 542 I-cancer
is 80 82 543 545 O
also 83 87 546 550 O
eligible 88 96 551 559 O
, 96 97 559 560 O
wherein 98 105 561 568 O
the 106 109 569 572 O
patient 110 117 573 580 O
is 118 120 581 583 O
not 121 124 584 587 O
required 125 133 588 596 O
to 134 136 597 599 O
be 137 139 600 602 O
in 140 142 603 605 O
complete 143 151 606 614 O
remission 152 161 615 624 O

Age 0 3 625 628 B-age
greater 4 11 629 636 O
than18 12 18 637 643 O
years 19 24 644 649 I-lower_bound

Any 0 3 650 653 O
other 4 9 654 659 O
cancer 10 16 660 666 B-cancer
from 17 21 667 671 O
which 22 27 672 677 O
the 28 31 678 681 O
patient 32 39 682 689 O
has 40 43 690 693 O
been 44 48 694 698 O
disease 49 56 699 706 O
- 56 57 706 707 O
free 57 61 707 711 O
for 62 65 712 715 O
three 66 71 716 721 B-upper_bound
years 72 77 722 727 I-upper_bound

ECOG 0 4 728 732 B-clinical_variable
performance 5 16 733 744 I-clinical_variable
status 17 23 745 751 I-clinical_variable
less 24 28 752 756 O
than 29 33 757 761 O
2 34 35 762 763 B-upper_bound
( 36 37 764 765 O
Phase 37 42 765 770 O
I 43 44 771 772 O
) 44 45 772 773 O
, 45 46 773 774 O
less 47 51 775 779 O
than 52 56 780 784 O
or 57 59 785 787 O
equal 60 65 788 793 O
to 66 68 794 796 O
1(Phase 69 76 797 804 B-upper_bound
II 77 79 805 807 O
) 79 80 807 808 O

HIV 0 3 809 812 B-chronic_disease
- 3 4 812 813 O
positive 4 12 813 821 O
patients 13 21 822 830 O
on 22 24 831 833 O
combination 25 36 834 845 B-treatment
antiretroviral 37 51 846 860 I-treatment
therapy 52 59 861 868 I-treatment
are 60 63 869 872 O
ineligible 64 74 873 883 O
because 75 82 884 891 O
of 83 85 892 894 O
possible 86 94 895 903 O
PK 95 97 904 906 O
interactions 98 110 907 919 O
with 111 115 920 924 O
TRC102 116 122 925 931 B-treatment

Hemoglobin 0 10 932 942 B-clinical_variable
greater 11 18 943 950 O
than 19 23 951 955 O
or 24 26 956 958 O
equal 27 32 959 964 O
to 33 35 965 967 O
10 36 38 968 970 B-lower_bound
g 39 40 971 972 I-lower_bound
/ 40 41 972 973 I-lower_bound
dL 41 43 973 975 I-lower_bound
without 44 51 976 983 O
transfusion 52 63 984 995 O
within 64 70 996 1002 O
1 71 72 1003 1004 B-upper_bound
week 73 77 1005 1009 I-upper_bound
prior 78 83 1010 1015 I-upper_bound
to 84 86 1016 1018 O
enrollment 87 97 1019 1029 O

History 0 7 1030 1037 O
of 8 10 1038 1040 O
allergic 11 19 1041 1049 O
reactions 20 29 1050 1059 O
attributed 30 40 1060 1070 O
to 41 43 1071 1073 O
compounds 44 53 1074 1083 O
of 54 56 1084 1086 O
similar 57 64 1087 1094 O
chemical 65 73 1095 1103 O
or 74 76 1104 1106 O
biologic 77 85 1107 1115 O
composition 86 97 1116 1127 O
to 98 100 1128 1130 O
TRC102 101 107 1131 1137 B-allergy_name
or 108 110 1138 1140 O
TMZ 111 114 1141 1144 B-allergy_name

Life 0 4 1145 1149 B-clinical_variable
expectancy 5 15 1150 1160 I-clinical_variable
of 16 18 1161 1163 O
greater 19 26 1164 1171 O
than 27 31 1172 1176 O
3 32 33 1177 1178 B-lower_bound
months 34 40 1179 1185 I-lower_bound

Patients 0 8 1186 1194 O
enrolling 9 18 1195 1204 O
in 19 21 1205 1207 O
the 22 25 1208 1211 O
expansion 26 35 1212 1221 O
cohorts 36 43 1222 1229 O
must 44 48 1230 1234 O
have 49 53 1235 1239 O
disease 54 61 1240 1247 O
amenable 62 70 1248 1256 O
to 71 73 1257 1259 O
biopsy 74 80 1260 1266 B-treatment
and 81 84 1267 1270 O
be 85 87 1271 1273 O
willing 88 95 1274 1281 O
to 96 98 1282 1284 O
undergo 99 106 1285 1292 O
pre 107 110 1293 1296 B-treatment
- 110 111 1296 1297 I-treatment
and 111 114 1297 1300 I-treatment
post 115 119 1301 1305 I-treatment
- 119 120 1305 1306 I-treatment
treatment 120 129 1306 1315 I-treatment
biopsies 130 138 1316 1324 I-treatment

Patients 0 8 1325 1333 O
must 9 13 1334 1338 O
be 14 16 1339 1341 O
able 17 21 1342 1346 O
to 22 24 1347 1349 O
swallow 25 32 1350 1357 O
whole 33 38 1358 1363 O
tablets 39 46 1364 1371 O
or 47 49 1372 1374 O
capsules 50 58 1375 1383 O
; 58 59 1383 1384 O
nasogastric 60 71 1385 1396 B-treatment
or 72 74 1397 1399 O
G 75 76 1400 1401 O
- 76 77 1401 1402 O
tube 77 81 1402 1406 O
administration 82 96 1407 1421 O
is 97 99 1422 1424 O
not 100 103 1425 1428 O
allowed 104 111 1429 1436 O

Patients 0 8 1437 1445 O
must 9 13 1446 1450 O
have 14 18 1451 1455 O
completed 19 28 1456 1465 O
any 29 32 1466 1469 O
chemotherapy 33 45 1470 1482 B-treatment
, 45 46 1482 1483 O
radiation 47 56 1484 1493 B-treatment
therapy 57 64 1494 1501 I-treatment
, 64 65 1501 1502 O
or 66 68 1503 1505 O
biologic 69 77 1506 1514 B-treatment
therapy 78 85 1515 1522 I-treatment
greater 86 93 1523 1530 O
than 94 98 1531 1535 O
or 99 101 1536 1538 O
equal 102 107 1539 1544 O
to 108 110 1545 1547 O
4 111 112 1548 1549 B-lower_bound
weeks 113 118 1550 1555 I-lower_bound
( 119 120 1556 1557 O
or 120 122 1557 1559 O
5 123 124 1560 1561 B-lower_bound
half 125 129 1562 1566 I-lower_bound
- 129 130 1566 1567 I-lower_bound
lives 130 135 1567 1572 I-lower_bound
, 135 136 1572 1573 O
whichever 137 146 1574 1583 O
is 147 149 1584 1586 O
shorter 150 157 1587 1594 O
) 157 158 1594 1595 O
prior 159 164 1596 1601 O
to 165 167 1602 1604 O
entering 168 176 1605 1613 O
the 177 180 1614 1617 O
study 181 186 1618 1623 O
( 187 188 1624 1625 O
6 188 189 1625 1626 B-lower_bound
weeks 190 195 1627 1632 I-lower_bound
for 196 199 1633 1636 O
nitrosoureas 200 212 1637 1649 B-treatment
or 213 215 1650 1652 O
mitomycin 216 225 1653 1662 B-treatment
C 226 227 1663 1664 I-treatment
) 227 228 1664 1665 O
. 228 229 1665 1666 O
Patients 230 238 1667 1675 O
must 239 243 1676 1680 O
be 244 246 1681 1683 O
greater 247 254 1684 1691 O
than 255 259 1692 1696 O
or 260 262 1697 1699 O
equal 263 268 1700 1705 O
to 269 271 1706 1708 O
2 272 273 1709 1710 B-lower_bound
weeks 274 279 1711 1716 I-lower_bound
since 280 285 1717 1722 O
any 286 289 1723 1726 O
prior 290 295 1727 1732 O
administration 296 310 1733 1747 O
of 311 313 1748 1750 O
a 314 315 1751 1752 O
study 316 321 1753 1758 B-treatment
drug 322 326 1759 1763 I-treatment
in 327 329 1764 1766 O
a 330 331 1767 1768 O
Phase 332 337 1769 1774 O
0 338 339 1775 1776 O
or 340 342 1777 1779 O
equivalent 343 353 1780 1790 O
study 354 359 1791 1796 O
and 360 363 1797 1800 O
greater 364 371 1801 1808 O
than 372 376 1809 1813 O
or 377 379 1814 1816 O
equal 380 385 1817 1822 O
to 386 388 1823 1825 O
1 389 390 1826 1827 B-lower_bound
week 391 395 1828 1832 I-lower_bound
from 396 400 1833 1837 O
palliative 401 411 1838 1848 B-treatment
radiation 412 421 1849 1858 I-treatment
therapy 422 429 1859 1866 I-treatment
. 429 430 1866 1867 O
Patients 431 439 1868 1876 O
must 440 444 1877 1881 O
have 445 449 1882 1886 O
recovered 450 459 1887 1896 O
to 460 462 1897 1899 O
eligibility 463 474 1900 1911 O
levels 475 481 1912 1918 O
from 482 486 1919 1923 O
prior 487 492 1924 1929 O
toxicity 493 501 1930 1938 O
or 502 504 1939 1941 O
adverse 505 512 1942 1949 O
events 513 519 1950 1956 O
. 519 520 1956 1957 O
Treatment 521 530 1958 1967 B-treatment
with 531 535 1968 1972 I-treatment
bisphosphonates 536 551 1973 1988 I-treatment
is 552 554 1989 1991 O
permitted 555 564 1992 2001 O

Patients 0 8 2002 2010 O
who 9 12 2011 2014 O
are 13 16 2015 2018 O
actively 17 25 2019 2027 O
receiving 26 35 2028 2037 O
any 36 39 2038 2041 O
other 40 45 2042 2047 O
investigational 46 61 2048 2063 B-treatment
agents 62 68 2064 2070 I-treatment

Patients 0 8 2071 2079 O
with 9 13 2080 2084 O
active 14 20 2085 2091 O
brain 21 26 2092 2097 B-cancer
metastases 27 37 2098 2108 I-cancer
or 38 40 2109 2111 O
carcinomatous 41 54 2112 2125 B-cancer
meningitis 55 65 2126 2136 I-cancer
are 66 69 2137 2140 O
excluded 70 78 2141 2149 O
from 79 83 2150 2154 O
this 84 88 2155 2159 O
clinical 89 97 2160 2168 O
trial 98 103 2169 2174 O
. 103 104 2174 2175 O
Patients 105 113 2176 2184 O
with 114 118 2185 2189 O
treated 119 126 2190 2197 O
brain 127 132 2198 2203 O
metastases 133 143 2204 2214 O
, 143 144 2214 2215 O
whose 145 150 2216 2221 O
brain 151 156 2222 2227 B-clinical_variable
metastatic 157 167 2228 2238 I-clinical_variable
disease 168 175 2239 2246 I-clinical_variable
has 176 179 2247 2250 O
remained 180 188 2251 2259 O
stable 189 195 2260 2266 O
for 196 199 2267 2270 O
greater 200 207 2271 2278 O
than 208 212 2279 2283 O
or 213 215 2284 2286 O
equal 216 221 2287 2292 O
to 222 224 2293 2295 O
4 225 226 2296 2297 B-lower_bound
weeks 227 232 2298 2303 I-lower_bound
without 233 240 2304 2311 O
requiring 241 250 2312 2321 O
steroid 251 258 2322 2329 B-treatment
and 259 262 2330 2333 O
anti 263 267 2334 2338 B-treatment
- 267 268 2338 2339 I-treatment
seizure 268 275 2339 2346 I-treatment
medications 276 287 2347 2358 I-treatment
are 288 291 2359 2362 O
eligible 292 300 2363 2371 O
to 301 303 2372 2374 O
participate 304 315 2375 2386 O

Phase 0 5 2387 2392 O
I 6 7 2393 2394 O
: 7 8 2394 2395 O
histologically 9 23 2396 2410 O
confirmed 24 33 2411 2420 O
solid 34 39 2421 2426 B-cancer
tumors 40 46 2427 2433 I-cancer
that 47 51 2434 2438 O
have 52 56 2439 2443 O
progressed 57 67 2444 2454 O
on 68 70 2455 2457 O
standard 71 79 2458 2466 O
therapy 80 87 2467 2474 B-treatment
known 88 93 2475 2480 O
to 94 96 2481 2483 O
prolong 97 104 2484 2491 O
survival 105 113 2492 2500 O
or 114 116 2501 2503 O
for 117 120 2504 2507 O
which 121 126 2508 2513 O
no 127 129 2514 2516 O
standard 130 138 2517 2525 O
treatment 139 148 2526 2535 B-treatment
options 149 156 2536 2543 O
exist 157 162 2544 2549 O

Phase 0 5 2550 2555 O
II 6 8 2556 2558 O
only 9 13 2559 2563 O
: 13 14 2563 2564 O
No 15 17 2565 2567 O
other 18 23 2568 2573 O
prior 24 29 2574 2579 O
malignancies 30 42 2580 2592 B-cancer
are 43 46 2593 2596 O
allowed 47 54 2597 2604 O

Phase 0 5 2605 2610 O
II 6 8 2611 2613 O
only 9 13 2614 2618 O
: 13 14 2618 2619 O
patients 15 23 2620 2628 O
with 24 28 2629 2633 O
colorectal 29 39 2634 2644 B-cancer
cancer 40 46 2645 2651 I-cancer
with 47 51 2652 2656 O
known 52 57 2657 2662 O
MSI 58 61 2663 2666 B-chronic_disease
- 61 62 2666 2667 I-chronic_disease
high 62 66 2667 2671 I-chronic_disease
disease 67 74 2672 2679 I-chronic_disease
who 75 78 2680 2683 O
have 79 83 2684 2688 O
not 84 87 2689 2692 O
previously 88 98 2693 2703 O
been 99 103 2704 2708 O
treated 104 111 2709 2716 O
with 112 116 2717 2721 O
immunotherapy 117 130 2722 2735 B-treatment
or 131 133 2736 2738 O
who 134 137 2739 2742 O
have 138 142 2743 2747 O
refused 143 150 2748 2755 O
treatment 151 160 2756 2765 B-treatment
with 161 165 2766 2770 I-treatment
immunotherapy 166 179 2771 2784 I-treatment

Phase 0 5 2785 2790 O
II 6 8 2791 2793 O
: 8 9 2793 2794 O
histologically 10 24 2795 2809 O
confirmed 25 34 2810 2819 O
colorectal 35 45 2820 2830 B-cancer
adenocarcinoma 46 60 2831 2845 I-cancer
post 61 65 2846 2850 O
at 66 68 2851 2853 O
least 69 74 2854 2859 O
two 75 78 2860 2863 B-lower_bound
lines 79 84 2864 2869 O
of 85 87 2870 2872 O
therapy 88 95 2873 2880 B-treatment
, 95 96 2880 2881 O
NSCLC 97 102 2882 2887 B-cancer
post 103 107 2888 2892 O
at 108 110 2893 2895 O
least 111 116 2896 2901 O
two 117 120 2902 2905 O
lines 121 126 2906 2911 O
of 127 129 2912 2914 O
therapy 130 137 2915 2922 O
, 137 138 2922 2923 O
or 139 141 2924 2926 O
granulosa 142 151 2927 2936 B-cancer
cell 152 156 2937 2941 I-cancer
ovarian 157 164 2942 2949 I-cancer
cancer 165 171 2950 2956 I-cancer
post 172 176 2957 2961 O
at 177 179 2962 2964 O
least 180 185 2965 2970 O
one 186 189 2971 2974 B-lower_bound
line 190 194 2975 2979 O
of 195 197 2980 2982 O
therapy 198 205 2983 2990 O
. 205 206 2990 2991 O
Patients 207 215 2992 3000 O
must 216 220 3001 3005 O
have 221 225 3006 3010 O
measurable 226 236 3011 3021 O
disease 237 244 3022 3029 O

Platelets 0 9 3030 3039 B-clinical_variable
greater 10 17 3040 3047 O
than 18 22 3048 3052 O
or 23 25 3053 3055 O
equal 26 31 3056 3061 O
to 32 34 3062 3064 O
100,000 35 42 3065 3072 B-lower_bound
/ 42 43 3072 3073 I-lower_bound
mcL 43 46 3073 3076 I-lower_bound

Pregnant 0 8 3077 3085 B-pregnancy
women 9 14 3086 3091 B-gender
are 15 18 3092 3095 O
excluded 19 27 3096 3104 O
from 28 32 3105 3109 O
this 33 37 3110 3114 O
study 38 43 3115 3120 O
because 44 51 3121 3128 O
the 52 55 3129 3132 O
effects 56 63 3133 3140 O
of 64 66 3141 3143 O
the 67 70 3144 3147 O
study 71 76 3148 3153 B-treatment
drugs 77 82 3154 3159 I-treatment
on 83 85 3160 3162 O
the 86 89 3163 3166 O
developing 90 100 3167 3177 O
fetus 101 106 3178 3183 O
are 107 110 3184 3187 O
unknown 111 118 3188 3195 O
. 118 119 3195 3196 O
Because 120 127 3197 3204 O
there 128 133 3205 3210 O
is 134 136 3211 3213 O
an 137 139 3214 3216 O
unknown 140 147 3217 3224 O
but 148 151 3225 3228 O
potential 152 161 3229 3238 O
risk 162 166 3239 3243 O
for 167 170 3244 3247 O
adverse 171 178 3248 3255 O
events 179 185 3256 3262 O
in 186 188 3263 3265 O
nursing 189 196 3266 3273 O
infants 197 204 3274 3281 O
secondary 205 214 3282 3291 O
to 215 217 3292 3294 O
treatment 218 227 3295 3304 B-treatment
of 228 230 3305 3307 O
the 231 234 3308 3311 O
mother 235 241 3312 3318 O
with 242 246 3319 3323 O
the 247 250 3324 3327 O
study 251 256 3328 3333 O
drugs 257 262 3334 3339 O
, 262 263 3339 3340 O
breastfeeding 264 277 3341 3354 O
should 278 284 3355 3361 O
be 285 287 3362 3364 O
discontinued 288 300 3365 3377 O
prior 301 306 3378 3383 O
to 307 309 3384 3386 O
the 310 313 3387 3390 O
first 314 319 3391 3396 O
dose 320 324 3397 3401 O
of 325 327 3402 3404 O
study 328 333 3405 3410 O
drug 334 338 3411 3415 O
and 339 342 3416 3419 O
women 343 348 3420 3425 O
should 349 355 3426 3432 O
refrain 356 363 3433 3440 O
from 364 368 3441 3445 O
nursing 369 376 3446 3453 O
throughout 377 387 3454 3464 O
the 388 391 3465 3468 O
treatment 392 401 3469 3478 O
period 402 408 3479 3485 O
and 409 412 3486 3489 O
for 413 416 3490 3493 O
3 417 418 3494 3495 O
months 419 425 3496 3502 O
following 426 435 3503 3512 O
the 436 439 3513 3516 O
last 440 444 3517 3521 O
dose 445 449 3522 3526 O
of 450 452 3527 3529 O
study 453 458 3530 3535 O
drug 459 463 3536 3540 O

Total 0 5 3541 3546 O
bilirubin 6 15 3547 3556 B-clinical_variable
less 16 20 3557 3561 O
than 21 25 3562 3566 O
or 26 28 3567 3569 O
equal 29 34 3570 3575 O
to1.5 35 40 3576 3581 O
X 41 42 3582 3583 I-upper_bound
institutional 43 56 3584 3597 I-upper_bound
ULN 57 60 3598 3601 I-upper_bound

Uncontrolled 0 12 3602 3614 O
intercurrent 13 25 3615 3627 O
illness 26 33 3628 3635 O
including 34 43 3636 3645 O
, 43 44 3645 3646 O
but 45 48 3647 3650 O
not 49 52 3651 3654 O
limited 53 60 3655 3662 O
to 61 63 3663 3665 O
, 63 64 3665 3666 O
serious 65 72 3667 3674 O
untreated 73 82 3675 3684 O
infection 83 92 3685 3694 B-chronic_disease
, 92 93 3694 3695 O
symptomatic 94 105 3696 3707 O
congestive 106 116 3708 3718 B-chronic_disease
heart 117 122 3719 3724 I-chronic_disease
failure 123 130 3725 3732 I-chronic_disease
, 130 131 3732 3733 O
unstable 132 140 3734 3742 B-chronic_disease
angina 141 147 3743 3749 I-chronic_disease
pectoris 148 156 3750 3758 I-chronic_disease
, 156 157 3758 3759 O
cardiac 158 165 3760 3767 B-chronic_disease
arrhythmia 166 176 3768 3778 I-chronic_disease
, 176 177 3778 3779 O
or 178 180 3780 3782 O
psychiatric 181 192 3783 3794 B-chronic_disease
illness 193 200 3795 3802 I-chronic_disease
/ 200 201 3802 3803 I-chronic_disease
social 201 207 3803 3809 I-chronic_disease
situations 208 218 3810 3820 I-chronic_disease
that 219 223 3821 3825 O
would 224 229 3826 3831 O
limit 230 235 3832 3837 O
compliance 236 246 3838 3848 O
with 247 251 3849 3853 O
study 252 257 3854 3859 O
requirements 258 270 3860 3872 O

creatinine 0 10 3873 3883 B-clinical_variable
clearance 11 20 3884 3893 I-clinical_variable
greater 21 28 3894 3901 O
than 29 33 3902 3906 O
or 34 36 3907 3909 O
equal 37 42 3910 3915 O
to 43 45 3916 3918 O
60 46 48 3919 3921 B-lower_bound
mL 49 51 3922 3924 I-lower_bound
/ 51 52 3924 3925 I-lower_bound
min/1.73 52 60 3925 3933 I-lower_bound
m2 61 63 3934 3936 I-lower_bound
for 64 67 3937 3940 O
patients 68 76 3941 3949 O
with 77 81 3950 3954 O
creatinine 82 92 3955 3965 B-clinical_variable
levels 93 99 3966 3972 I-clinical_variable
greater 100 107 3973 3980 O
than 108 112 3981 3985 O
1.5 113 116 3986 3989 B-lower_bound
mg 117 119 3990 3992 I-lower_bound
/ 119 120 3992 3993 I-lower_bound
dL 120 122 3993 3995 I-lower_bound

creatinine 0 10 3996 4006 B-clinical_variable
less 11 15 4007 4011 I-clinical_variable
than 16 20 4012 4016 O
or 21 23 4017 4019 O
equal 24 29 4020 4025 O
to 30 32 4026 4028 O
1.5 33 36 4029 4032 B-upper_bound
X 37 38 4033 4034 I-upper_bound
institutional 39 52 4035 4048 I-upper_bound
ULN 53 56 4049 4052 I-upper_bound

